Sequence information
Variant position: 1638 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1988 The length of the canonical sequence.
Location on the sequence:
GRILRLVKGAKGIRTLLFAL
M MSLPALFNIGLLLFLVMFIY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human GRILRLVKGAKGIRTLLFALM MSLPALFNIGLLLFLVMFIY
Mouse GRILRLIKGAKGIRTLLFALM MSLPALFNIGLLLFLVMFIY
Rat GRILRLIKGAKGIRTLLFALM MSLPALFNIGLLLFLVMFIY
Rabbit GRILRLIKGAKGIRTLLFALM MSLPALFNIGLLLFLVMFIY
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 1988
Sodium channel protein type 9 subunit alpha
Topological domain
1625 – 1643
Cytoplasmic
Repeat
1497 – 1795
IV
Mutagenesis
1643 – 1643
A -> D. Depolarizes the voltage-dependence of steady-state fast inactivation; enhances persistent current.
Mutagenesis
1643 – 1643
A -> K. No effect on voltage-dependence of steady-state fast inactivation.
Mutagenesis
1643 – 1643
A -> V. No effect on voltage-dependence of steady-state fast inactivation.
Helix
1628 – 1639
Literature citations
SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.
Fertleman C.R.; Baker M.D.; Parker K.A.; Moffatt S.; Elmslie F.V.; Abrahamsen B.; Ostman J.; Klugbauer N.; Wood J.N.; Gardiner R.M.; Rees M.;
Neuron 52:767-774(2006)
Cited for: VARIANTS PEPD CYS-1007; PHE-1309; ASP-1309; PHE-1310; THR-1472; VAL-1473; ILE-1475 AND LYS-1638; CHARACTERIZATION OF VARIANTS PEPD THR-1472; ILE-1475 AND LYS-1638; FUNCTION;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.